January 21, 2021 – Announcements
Early career investigators are a unique reservoir of new ideas, innovation, and excellence in cancer research. To celebrate this, we welcome you to join the 8th Annual DF/HCC Celebration of Early Investigators in Cancer...
January 19, 2021 – Announcements
Dr. Kanarek joins DF/HCC as a member of the Leukemia Program.
December 30, 2020 – Funding
The National Cancer Institute (NCI) is providing an opportunity for supplemental funding to support exploratory research studies to expand the current understanding of cancer stigma, assess its impact on cancer control...
December 30, 2020 – Funding
A funding opportunity previously limited to DFCI investigators (the Dana-Farber/Novartis Drug Discovery & Translational Research Program, DDTRP) will soon open to all independent investigators at DF/HCC member...
December 17, 2020 – Event Highlight
The DF/HCC Cancer Data Science Program & Harvard Chan Bioinformatics Core Joint Symposium on scRNAseq Methodology recorded video is now available.
December 14, 2020 – COVID-19
The policy exceptions announced on March 23, 2020 have been extended until June 2021. An updated note to file has been posted.
December 08, 2020
NCI has just released a time sensitive Request for Information (RFI) seeking input from all parties who may be interested in the re-competition of the NCI’s Frederick National Laboratory for Cancer Research (FNLCR)....
December 08, 2020 – Funding
The DF/HCC Lymphoma and Myeloma Program is currently seeking applications for Translational Projects in Lymphoma for a new Specialized Program in Research Excellence (SPORE), with applications due on December 14, 2020 by...
November 25, 2020 – News
"with this confirmation that our regulatory base is firm, we can focus on efficiency and collaboration with our investigators."
November 20, 2020 – PRMS
On Friday, November 20th, iRIS will undergo a few minor updates. Please review the summary of changes and friendly reminders below. The Wiki will be updated accordingly.
The DF/HCC Connect:Science seminar series offers remote participation through Zoom to pull our community of faculty, trainees, and lab staff together during this difficult time and it promotes engagement during these next several weeks.
DF/HCC’s Center for Cancer Equity and Engagement is working to bring DF/HCC research and communities together to eliminate cancer disparities in Massachusetts.
This is a collaboration between Dana-Farber/Harvard Cancer Center and the David H. Koch Institute for Integrative Cancer Research, designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care.
